An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study
NCT ID: NCT05192200 Phase: PHASE2 Status: COMPLETED Enrollment: 24 Completion: 2023-11-20
Conditions
Dermatomyositis
Interventions
Anti-Beta Interferon (PF-06823859)
Summary
The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.
Primary Outcome
Number of Participants With Treatment Emergent Adverse Events (TEAEs)